These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 29076114)

  • 21. Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.
    Nevskaya T; Zheng B; Baxter CA; Ramey DR; Pope JE; Baron M;
    Rheumatology (Oxford); 2020 Jul; 59(7):1715-1724. PubMed ID: 31774531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis.
    Kilic G; Kilic E; Akgul O; Ozgocmen S
    Int J Rheum Dis; 2016 Apr; 19(4):405-11. PubMed ID: 24283757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients.
    Ruaro B; Sulli A; Pizzorni C; Paolino S; Smith V; Alessandri E; Trombetta AC; Alsheyyab J; Cutolo M
    Microvasc Res; 2018 Jan; 115():28-33. PubMed ID: 28834709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
    Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
    Front Immunol; 2021; 12():686483. PubMed ID: 34276673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Skin Thickness Measurements with Corneal Biomechanical Properties and Dry Eye Tests in Systemic Sclerosis.
    Ayhan Z; Kaya M; Ozturk T; Arikan G; Birlik M
    Ocul Immunol Inflamm; 2019; 27(7):1138-1143. PubMed ID: 30110190
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.
    Solanki KK; Hor C; Chang WSJ; Frampton C; White DHN
    Int J Rheum Dis; 2017 Jun; 20(6):767-773. PubMed ID: 28261995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients.
    Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A
    Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
    Nevskaya T; Baron M; Pope JE;
    Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
    Yamaguchi Y; Ono J; Masuoka M; Ohta S; Izuhara K; Ikezawa Z; Aihara M; Takahashi K
    Br J Dermatol; 2013 Apr; 168(4):717-25. PubMed ID: 23110679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin/Lung Fibrosis.
    Bellocchi C; Ying J; Goldmuntz EA; Keyes-Elstein L; Varga J; Hinchcliff ME; Lyons MA; McSweeney P; Furst DE; Nash R; Crofford LJ; Welch B; Goldin JG; Pinckney A; Mayes MD; Sullivan KM; Assassi S
    Arthritis Rheumatol; 2021 Apr; 73(4):660-670. PubMed ID: 33131208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis.
    Simon D; Balogh P; Bognár A; Kellermayer Z; Engelmann P; Németh P; Farkas N; Minier T; Lóránd V; Czirják L; Berki T
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):30-36. PubMed ID: 27056741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-sectional study using the University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Tract Instrument 2.0 (UCLA SCTC GIT 2.0) for gastrointestinal disorders of systemic sclerosis.
    Hisada S; Takeuchi S; Tozawa T; Yamada Y; Ito Y; Kodera M
    J Dermatol; 2024 Oct; 51(10):1329-1334. PubMed ID: 38963343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis.
    Sulli A; Ruaro B; Smith V; Paolino S; Pizzorni C; Pesce G; Cutolo M
    Arthritis Res Ther; 2017 Mar; 19(1):61. PubMed ID: 28320447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
    Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
    Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of modified Rodnan skin score and esophageal manometry in systemic sclerosis: a study correlating severity of skin and esophageal involvement by objective measures.
    Arif T; Adil M; Singh Sodhi J; Hassan I
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Dec; 27(4):169-173. PubMed ID: 30564828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials.
    Amjadi S; Maranian P; Furst DE; Clements PJ; Wong WK; Postlethwaite AE; Khanna PP; Khanna D;
    Arthritis Rheum; 2009 Aug; 60(8):2490-8. PubMed ID: 19644851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-assessment of skin tightness severity by scleroderma patients.
    Daungkum K; Foocharoen C; Mahakkanukrauh A; Suwannaroj S; Thinkhamrop B; Nanagara R
    Int J Rheum Dis; 2016 Oct; 19(10):989-995. PubMed ID: 27126197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline Plasma Cell Gene Signature Predicts Improvement in Systemic Sclerosis Skin Scores Following Treatment With Inebilizumab (MEDI-551) and Correlates With Disease Activity in Systemic Lupus Erythematosus and Chronic Obstructive Pulmonary Disease.
    Streicher K; Sridhar S; Kuziora M; Morehouse CA; Higgs BW; Sebastian Y; Groves CJ; Pilataxi F; Brohawn PZ; Herbst R; Ranade K
    Arthritis Rheumatol; 2018 Dec; 70(12):2087-2095. PubMed ID: 29956883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.